|
|
 |
| Primary Symbols & Exchanges: |
| CRYO - London |
| - Berlin-Bremen Stock Exchange |
| - Pink Sheets |
|
|
| Primary Industry: |
| Biotechnology |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activity is the collection, isolation, processing and storage of adult human stem cells from cord blood, bone marrow and other sources for autologeous use for treating numerous life threatening diseases. The Group currently trades in 36 markets, predominantly in Europe, but with operations in several non-European territories. Stem cells are unspecialised cells which have the ability to replicate and transform into a range of specialised cell types which form the basis of different human tissues. The application of stem cells for the regeneration of human tissue is used in medical therapies. The Group's services allow parents and guardians to collect and cryogenically preserve a child's stem cells, contained either in the blood or wall of the umbilical cord, so that they may be used in medical therapies if the child so requires during his or her lifetime. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Cryo-Save Group N.V.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
